Largos supervivientes y terapias dirigidas en melanoma avanzado - page 27

Atezo + Cobi + Vem

Atezo 800 mg, cobi 60 mg, vem 720 mg

Cobi + Vem

D1-21: Cobi 60 mg, vem

960 mg

D22-28: Vem 720 mg

28 días

C2+

Atezo

(IV q2w)

800 mg

Vem

(PO BID)

960 mg

720 mg

Cobi

(PO QD, 21/7)

60 mg

Cohorte de expansión

Uso experimental, no autorizado

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,17,18,19,20,21,22,23,24,25,26 28,29,30,31,32,33,34,35,36,37,...46